Cargando…

Age comorbidity scores as risk factors for 90‐day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population‐Based Study

BACKGROUND: To estimate easily assessed preoperative factors for predicting 90‐day mortality in patients with a pancreatic head adenocarcinoma (PHA) receiving a pancreaticoduodenectomy. METHODS: We analyzed data from the Taiwan Cancer Registry Database of patients with a PHA who received a pancreati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shia, Ben‐Chang, Qin, Lei, Lin, Kuan‐Chou, Fang, Chih‐Yuan, Tsai, Lo‐Lin, Kao, Yi‐Wei, Wu, Szu‐Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970054/ https://www.ncbi.nlm.nih.gov/pubmed/31789464 http://dx.doi.org/10.1002/cam4.2730

Ejemplares similares

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery
por: Qin, Lei, et al.
Publicado: (2018)

A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy
por: Soong, Ruey-Shyang, et al.
Publicado: (2022)

Outcomes for Elderly Patients Aged 70 to 80 Years or Older with Locally Advanced Oral Cavity Squamous Cell Carcinoma: A Propensity Score–Matched, Nationwide, Oldest Old Patient–Based Cohort Study
por: Shia, Ben-Chang, et al.
Publicado: (2020)

Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case‐control frequency‐matched study
por: Qin, Lei, et al.
Publicado: (2018)

Preoperative Predictors for 90-Day Mortality after Pancreaticoduodenectomy in Patients with Adenocarcinoma of the Ampulla of Vater: A Single-Centre Retrospective Cohort Study
por: Fernandez-Placencia, Ramiro, et al.
Publicado: (2021)

Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer
por: Maibom, Sophia L., et al.
Publicado: (2021)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment
por: Su, Po‐Lan, et al.
Publicado: (2019)

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

Prognostic value of Kinesin‐4 family genes mRNA expression in early‐stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
por: Han, Quanfa, et al.
Publicado: (2019)

Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms
por: Zhou, Xin, et al.
Publicado: (2019)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma
por: Choi, Munseok, et al.
Publicado: (2021)

Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Chen, Kexin, et al.
Publicado: (2021)

Demographic, Injury Characteristics, and Comorbidity Differences Between Youth with >28 Day and >90 Day Recovery from Concussion
por: Young, Julie A., et al.
Publicado: (2022)

Appendiceal adenocarcinoma is associated with better prognosis than cecal adenocarcinoma: a population-based comparative survival study
por: Chen, George, et al.
Publicado: (2023)

Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?
por: Kang, Chang Moo, et al.
Publicado: (2020)

Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries
por: Dessai, Sampada B., et al.
Publicado: (2018)

Effect of Enhanced Recovery After Surgery program on hospital stay and 90-day readmission after pancreaticoduodenectomy: a single, tertiary center experience in Korea
por: Kim, Doo-Hun, et al.
Publicado: (2021)

KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis
por: Wang, Wenlong, et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Xiang, Zi-jun, et al.
Publicado: (2020)

Tumor location is an independent predictive factor for distant metastasis and metastatic sites of rectal adenocarcinoma in patients receiving total mesorectal excision
por: Chen, Chien-Hsin, et al.
Publicado: (2018)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis
por: Lai, Yen‐Ling, et al.
Publicado: (2021)

Chemoradiation After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma is it of Proven Benefit?
por: Garden, O. J.
Publicado: (1999)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Mesenteric approach during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
por: Hirono, Seiko, et al.
Publicado: (2017)

Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma
por: Liu, Dao-ning, et al.
Publicado: (2016)

Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA‐mRNA functional synergistic network
por: Zhu, Xiongwen, et al.
Publicado: (2019)

Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
por: Lin, Yu, et al.
Publicado: (2019)

Statin use and its association with decreased risk of esophageal squamous cell carcinoma in betel nut chewers
por: Lin, Chih‐Lang, et al.
Publicado: (2023)

Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study
por: Zhang, Xiu-Ping, et al.
Publicado: (2023)

Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy
por: Binziad, Salah, et al.
Publicado: (2013)

Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer
por: Ge, Xuan, et al.
Publicado: (2023)

Pylorus-preserving pancreaticoduodenectomy versus standard pancreaticoduodenectomy in the treatment of duodenal papilla carcinoma
por: Zhao, Rui, et al.
Publicado: (2018)

A laparoscopic pancreaticoduodenectomy for pancreatic adenocarcinoma in a patient with situs inversus totalis
por: Hussan, Maher Al, et al.
Publicado: (2021)

Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
por: Jiang, Yu-Li, et al.
Publicado: (2019)

Comparison of Laparoscopic and Open Pancreaticoduodenectomy for the Treatment of Nonpancreatic Periampullary Adenocarcinomas
por: Meng, Ling-Wei, et al.
Publicado: (2018)

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
por: Du, Jiali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2srdc8d2njplsrc900cio2eobr